Castle Biosciences (CSTL) Inventory Average (2019 - 2026)

Castle Biosciences (CSTL) has 8 years of Inventory Average data on file, last reported at $10.4 million in Q1 2026.

• Quarterly Inventory Average rose 38.25% year-over-year to $10.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 38.25% YoY) and the FY2025 annual result came in at $9.2 million, up 14.38% from the prior year.
• Inventory Average grew to $10.4 million in Q1 2026 per CSTL's latest filing, from $9.5 million in the prior quarter.
• The five-year high for Inventory Average was $10.4 million in Q1 2026, with the low at $2.2 million in Q1 2022.
• Average Inventory Average over 5 years is $6.4 million, with a median of $7.3 million recorded in 2024.
• Year-over-year, Inventory Average surged 94.46% in 2023 and slipped 3.87% in 2025.
• Castle Biosciences' Inventory Average stood at $3.9 million in 2022, then jumped by 76.19% to $6.9 million in 2023, then climbed by 7.26% to $7.4 million in 2024, then advanced by 28.54% to $9.5 million in 2025, then climbed by 9.58% to $10.4 million in 2026.
• Business Quant data shows CSTL's Inventory Average at $10.4 million in Q1 2026, $9.5 million in Q4 2025, and $8.5 million in Q3 2025.